Commit To Purchase Jounce Therapeutics At $2.50, Earn 28.1% Annualized Using Options
December 27, 2018 at 11:10 AM EST
Investors considering a purchase of Jounce Therapeutics Inc (JNCE) shares, but tentative about paying the going market price of $3.07/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2019 put at the $2.50 strike, which has a bid at the time of this writing of 15 cents..